$ZS

RUBIN KEVIN sold $74K of ZS

RUBIN KEVIN (Chief Financial Officer) sold 503 shares of Zscaler, Inc. (ZS) at an average of $147.12 ($144.74–$148.81) across 5 trades on 2026-07-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RUBIN KEVIN
Published Jul 28, 2026, 11:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 28, 2026, 11:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZS
Neutral
high confidence
Mentioned
$ZS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZSNeutralLow
01

Why it matters

The newest disclosed fact is the specific open-market sale details (date, share count, price range, and total value) under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 structure and modest dollar value suggest limited actionable impact.

03

What to watch

The filing does not disclose reasons for sale, and the share count ($74k) is small relative to typical company market caps, limiting signal strength.

Relevance 2/10Novelty 2/10Timing: after-hours filing posted on SEC EDGAR (filed 2026-07-28)

Background

The article is an SEC Form 4 insider transaction disclosure for Zscaler, Inc. (ZS) by CFO Kevin Rubin.

Company-level read

Ticker impact

$ZSNeutralHigh confidence
Context

Zscaler CFO Kevin Rubin filed a Form 4 showing an open-market sale of 503 shares at a weighted average price of $147.1218.

Expected impact

Low likelihood of a sustained price move solely from this filing; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The transaction is explicitly an open-market sale and pre-arranged under a Rule 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with periods of valuation or liquidity needs, so traders may still watch for follow-on filings.

Key entities

  • Zscaler, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Kevin Rubin

    Chief Financial Officer who sold shares via an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.